The Chairman of the Pharmaceutical Authority receives the delegation of the Pharmaceutical Authority in the State of Zambia
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, received an official delegation from the Pharmaceutical Regulatory Authority in the State of Zamra, with the aim of strengthening bilateral cooperation between the two countries in the drug field, and discussing the mechanisms of facilitating the procedures for registration of Egyptian medicines in the Zambian market. The pioneering of Egypt in supporting health integration on the African continent, and pointed out that the Egyptian Drug Authority has wide international recognition, as it is the first organizational body in Africa to obtain the third maturity level by the World Health Organization in the manufacture of medicines and vaccines.
& nbsp; African. And strengthening his competitiveness at the regional and international level. Al -Zambi on a field tour of the Egyptian city of medicine & quot; Gibbetovarm & quot;, one of the largest pharmaceutical monuments in the Middle East and Africa. During which the delegation was briefed on the latest technologies used in the manufacture of pharmaceutical preparations, and received a detailed presentation on modern manufacturing operations, and the quality standards used to ensure the products match the highest international specifications, and the efforts of the city of the medicine were reviewed in supporting drug innovation and enhancing local production, in a way that contributes to achieving drug security and increasing the competitiveness of Egyptian products in foreign markets.
and expressed members The Zambian delegation for their praise of the advanced manufacturing capabilities that it possesses & quot, Gibbetovarm & quot, and its commitment to applying the highest international quality standards, and its role in enhancing Egypt’s position as a leading country in the field of pharmaceutical industry at the regional and international levels. Tamer Al -Husseini, Vice -Chairman of the Egyptian Pharmaceutical Authority, d. Rasha Ziada, Assistant Chairman of the Egyptian Pharmaceutical Authority for Technical Development and Capacity Development, d. Hanan Amin, Head of the Central Administration for Pharmaceutical Programs, d. Amani Jawdat, Associate Chairman and Supervisor of the Central Administration of the Office of the Chairman of the Authority, Dr. Osama Hatem, Associate Chairman of the Authority for Policies and International Cooperation and supervisor of the Central Administration for Pharmaceutical Policies and Market Support, d. Wadian Younis, Head of the Central Administration for Drug Control, d. Hamada Jamal, Director General of Registration in the Central Administration of Pharmaceutical preparations and the assistant head of the Authority for the Affairs of Development and Modernization of Medical Carry Carcine systems, d. Dalia Abu Hussein, Director General of the General Administration for Quality Confirmation, representative of the Authority in the Continental Committee for the Quality of African Medicines of the African Union Agency. Makomani Siangia, Director General of the Zambian Medicines Regulatory Authority, d. Bonavitor Shelindi, chief analyst of the Zambian Authority and Chairman of the Continental Committee for the Quality of African Medicines of the African Union Agency, d. Niabi Liuko, Director of Registration Department at the Zambian Authority, d. Don Sandy Mwangana, the pharmaceutical inspection official of the Zambian Authority.
